Research Article
Impact of HIV-1 Infection and Antiretroviral Therapy on Bone Homeostasis and Mineral Density in Vertically Infected Patients
Table 2
Characteristics of the population that underwent DXA.
| Age | Mean (years) | 18.8 |
| Sex | Male | 21 (45%) | Female | 26 (55%) |
| BMI | Mean (kg/m2) | 20.7 |
| Race | Caucasian | 32 (68%) | African | 15 (32%) |
| Smoking habits | Yes | 21 (45%) | No | 26 (55%) |
| CDC classification | N/A (not/mildly symptomatic) | 18 (38%) | B (moderately symptomatic) | 20 (43%) | C (severely symptomatic) | 9 (19%) |
| Physical activity | Poor | 5 (13%) | Sufficient | 9 (24%) | Good | 24 (63%) |
| Ongoing therapy | Fusion Inhibitors | 3 (6%) |
| | NRTIs | 43 (91%) |
| | NtRTIs | 20 (42%) |
| | NNRTIs | 15 (32%) |
| | Integrase Inhibitors | 6 (13%) |
| | PIs | 35 (74%) |
| Previous therapy | Fusion Inhibitors | 2 (4%) |
| | NRTIs | 46 (98%) |
| | NtRTIs | 23 (49%) |
| | NNRTIs | 28 (60%) |
| | Integrase Inhibitors | 3 (6%) |
| | PIs | 39 (83%) |
|
|
Legend: NRTIs: nucleoside reverse transcriptase inhibitors. NtRTIs: nucleotide reverse transcriptase inhibitors. NNRTIs: nonnucleoside reverse transcriptase inhibitors. PIs: protease inhibitors.
|